Radiology News
Get the latest on radiology with press releases highlighting research, innovations, and advancements shaping medical imaging and diagnostics. Stay informed on key developments in radiology and explore opportunities in imaging technology and patient care.
Jun 9, 2026 at 9:22 AM
Marie® by Leo Cancer Care Makes History at Stanford Medicine — World First in Compact Upright Proton Therapy
LONDON--(BUSINESS WIRE)--A child was the first patient treated at Stanford Medicine using Leo Cancer Care's Marie® — world's first compact upright proton therapy....
Jun 9, 2026 at 9:19 AM
Mosaic Clinical Technologies™ Launches Mosaic Reporting™, an AI-Native Reporting Platform Built for Radiology Workflows
NASHVILLE, Tenn.--(BUSINESS WIRE)--Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, today announced the commercial launch of Mosaic Reporting™, a new class of AI-native radiology reporting solution available as part of MosaicOS™. Mosaic Reporting is already deployed to thousands of radiologists through Radiology Partners-affiliated practices, giving Mosaic a scaled real-world environment to refine and expand the platform. Powered by foundation models developed by...
Jun 9, 2026 at 9:00 AM
GE HealthCare advancing enterprise imaging with cloud-enabled solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical imaging departments today are under immense pressure from all sides including rising imaging volumes and increasing case complexity, while staffing shortages continue to grow. According to the American College of Radiology (ACR), radiologist workforce shortages have been identified as the biggest th...
Jun 9, 2026 at 9:00 AM
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that Dr. Jost Reinhard has been appointed President of the Radiology business within Bayer’s Pharmaceuticals Division, effective August 1, 2026. In his new capacity, he will report to Stefan Oelrich, Member of the Board of Management of Bayer AG and President of the company’s Pharmaceuticals Division. Reinhard follows Nelson Ambrogio, who became President of Bayer U.S. Pharmaceuticals in May 2026. “With a compelling performance in recent ye...
Jun 9, 2026 at 6:30 AM
Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study continues to demonstrate a favorable long‑term safety profile1, with no new cardia...
Jun 9, 2026 at 6:00 AM
Harrison.ai Releases Harrison.Rad 1.5, a Radiology Foundation Model That Can Draft Reports from Images, Priors and Clinical Context and the Only Model to Pass Radiology's New Board-exam Standard
BOSTON--(BUSINESS WIRE)--Harrison.ai releases Harrison.Rad 1.5, a radiology foundation model that can draft reports from images, priors and clinical context....
Jun 8, 2026 at 8:34 PM
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has approved the Biologics License Application (BLA) for TIVDAK® (tisotumab vedotin for injection) for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. This approval is based on results from the global, randomized, Phase 3 innovaTV 301 clinical trial, wh...
Jun 8, 2026 at 10:03 AM
The Massachusetts Innovation Network Announces The 2026 Eddies Finalists
BURLINGTON, Mass.--(BUSINESS WIRE)--Now celebrating its 40th anniversary, The Eddies is the oldest and longest-running innovation-boosting program in the Northeast U.S. Over the next six months, these ground-breaking startups will participate in a no-equity, no-cost program offering tailored mentorship, strategy guidance, leadership development, and access to curated resources and funding opportunities. Finalists were selected by a panel of expert, independent judges based on the disruptive pot...
Jun 8, 2026 at 8:00 AM
AdvanCell Strengthens Executive Leadership to Accelerate U.S. Expansion and Scale its Global Targeted Alpha Therapy Platform
BOSTON & BRISBANE, Australia--(BUSINESS WIRE)--AdvanCell strengthens its leadership team with key U.S. appointments and continued investment in isotope innovation and platform growth....
Jun 8, 2026 at 2:00 AM
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
LJUBLJANA, Slovenia--(BUSINESS WIRE)--Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the lead...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.